Book Value Per Share: The amount of equity available to shareholders expressed on a per common share basis. Calculated as: Total Shareholders Equity / Common Shares Outstanding
Kiniksa Pharmaceuticals International, plc (KNSA) had Book Value Per Share of $8.39 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$243.60M |
|
$25.43M |
|
$23.57M |
|
$220.03M |
|
$216.41M |
|
$27.19M |
|
$3.95M |
|
$31.14M |
|
$31.14M |
|
$25.43M |
|
$25.43M |
|
$25.43M |
|
$25.43M |
|
$27.19M |
|
$27.67M |
|
77.58M |
|
83.40M |
|
$0.33 |
|
$0.30 |
|
| Balance Sheet Financials | |
$668.63M |
|
$2.58M |
|
$227.48M |
|
$896.11M |
|
$171.25M |
|
-- |
|
$70.71M |
|
$241.96M |
|
$654.15M |
|
$639.40M |
|
$654.15M |
|
77.98M |
|
| Cash Flow Statement Financials | |
$97.39M |
|
$-105.50M |
|
$18.18M |
|
$165.60M |
|
$175.68M |
|
$10.08M |
|
$21.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.90 |
|
-- |
|
-- |
|
-- |
|
-- |
|
90.32% |
|
11.16% |
|
11.16% |
|
-- |
|
12.79% |
|
10.44% |
|
$96.57M |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
0.33 |
|
10.37 |
|
8.68 |
|
3.89% |
|
3.98% |
|
2.84% |
|
3.89% |
|
|
Book Value Per Share |
$8.39 |
$1.16 |
|
$1.17 |
|